Late Presentation of Multidrug-Resistant Pulmonary Tuberculosis 27 Years after Treated Intracranial Tuberculoma: A Case Report
DOI:
https://doi.org/10.5281/zenodo.22810028Keywords:
Multidrug-resistant tuberculosis, late recurrence, intracranial tuberculoma, pulmonary tuberculosis, bedaquilineAbstract
IntroductionReactivation of tuberculosis after decades of apparent cure is not unheard of, but multidrug-resistant disease appearing this late — particularly after a central nervous system infection — is rarely documented.
Case PresentationWe describe a 58-year-old woman who developed fever, weight loss, and a persistent cough twenty-seven years after successful treatment of an intracranial tuberculoma. A cavitary lesion in the right upper lobe led to a diagnosis of multidrug-resistant tuberculosis, with resistance to both rifampicin and isoniazid confirmed on molecular and phenotypic testing. She began a bedaquiline-based regimen in line with current WHO guidance and went on to achieve early culture conversion along with steady clinical and radiological recovery.
ConclusionsThis case is a reminder of how unpredictable tuberculosis latency can be, reinforces the diagnostic value of molecular testing, and confirms the effectiveness of contemporary MDR-TB regimens — while making clear that clinical vigilance should not lapse even decades after apparent cure.
References
1. World Health Organization. Global tuberculosis report 2023. Geneva: WHO; 2023.
2. Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med. 2013;368:745-55.
3. Barry CE 3rd, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis. Nat Rev Microbiol. 2009;7:845-55.
4. Gengenbacher M, Kaufmann SH. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev. 2012;36:514-32.
5. Rock RB, Olin M, Baker CA, et al. Central nervous system tuberculosis. Clin Microbiol Rev. 2008;21:243-61.
6. Dutta NK, Karakousis PC. Latent tuberculosis infection. Microbiol Spectr. 2014;2:1-17.
7. Andrews JR, Noubary F, Walensky RP, et al. Risk of progression to active tuberculosis following reinfection. Am J Respir Crit Care Med. 2012;186:106-12.
8. Mitchison D, Davies G. The chemotherapy of tuberculosis: past, present and future. Int J Tuberc Lung Dis. 2012;16:724-32.
9. O'Garra A, Redford PS, McNab FW, et al. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475-527.
10. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005-15.
11. Diacon AH, Pym A, Grobusch MP, et al. Multidrug-resistant tuberculosis and bedaquiline. N Engl J Med. 2014;371:723-32.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Srinivasa Reddy Kesari (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in ClinSphere Journals are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License.
This license permits unrestricted use, sharing, distribution, reproduction, adaptation, and commercial use of the published work in any medium or format, provided that appropriate credit is given to the original author(s) and the original source, a link to the Creative Commons license is provided, and any changes made are clearly indicated.
Authors retain copyright of their work and grant ClinSphere Journals a non-exclusive license to publish, archive, index, and disseminate the article.
To view a copy of this license, visit:
https://creativecommons.org/licenses/by/4.0/